FOX CHASE CANCER CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
Phase 2
Withdrawn
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT00084565
Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2010-02-12
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00084526
- Locations
- 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
Phase 1
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2010-02-12
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT00084591
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer
Not Applicable
Completed
- Conditions
- Sexuality and Reproductive IssuesSexual DysfunctionProstate Cancer
- Interventions
- Radiation: radiation therapy
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 116
- Registration Number
- NCT00084552
- Locations
- 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2010-02-12
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00084513
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Radiation: Radiation therapy
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2016-03-03
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 78
- Registration Number
- NCT00084539
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
Phase 1
Completed
- Conditions
- Colorectal CancerPancreatic Cancer
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2013-07-11
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00006387
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2
Completed
- Conditions
- Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT00003944
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
Phase 1
Completed
- Conditions
- LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2013-07-11
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00005021
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
Phase 2
Completed
- Conditions
- Carcinoma of Unknown PrimaryLung Cancer
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT00003943
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Johns Hopkins Oncology Center, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath